Deconstructing the axon: Wallerian degeneration and the ubiquitin-proteasome system

Trends in Neurosciences

Volumn 27, Issue 1, 2004, Pages 3-6

  Ehlers, Michael D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; MULTIENZYME COMPLEX; PROTEASOME; UBIQUITIN;

ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; BIOSYNTHESIS; GENETIC LINKAGE; HUMAN; METABOLISM; NERVE DEGENERATION; NERVE FIBER; NERVE FIBER TRANSECTION; NERVE FIBER TRANSPORT; NERVE INJURY; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

EID: 0346156093     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2003.10.015     Document Type: Short Survey

References (35)

1. Griffin J.W., et al. Axonal degeneration and other disorders of the axonal cytoskeleton. Stys P.K. The Axon. 1995;375-390 Oxford University Press.
2. Finn J.T., et al. Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J. Neurosci. 20:2000;1333-1341.
3. Waller A. Experiments on the section of glossopharyngeal and hypoglossal nerves of the frog and observations of the alternatives produced thereby in the structure of their primitive fibers. Philos Trans R Soc Lond. 140:1850;423-429.
4. Raff M.C., et al. Axonal self-destruction and neurodegeneration. Science. 296:2002;868-871.
5. Coleman M.P., Perry V.H. Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci. 25:2002;532-537.
6. Lunn E.R., et al. Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur. J. Neurosci. 1:1989;27-33.
7. Glass J.D., et al. Prolonged survival of transected nerve fibres in C57BL/Ola mice is an intrinsic characteristic of the axon. J. Neurocytol. 22:1993;311-321.
8. Mack T.G., et al. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat. Neurosci. 4:2001;1199-1206.
9. Zhai Q., et al. Involvement of the ubiquitin-proteasome system in the early stages of Wallerian degeneration. Neuron. 39:2003;217-225.
10. Glickman M.H., Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82:2002;373-428.
11. Hicke L. Protein regulation by monoubiquitin. Nat. Rev. Mol. Cell Biol. 2:2001;195-201.
12. Wilkinson K.D. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J. 11:1997;1245-1256.
13. Chung C.H., Baek S.H. Deubiquitinating enzymes: their diversity and emerging roles. Biochem. Biophys. Res. Commun. 266:1999;633-640.
14. George E.B., et al. Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J. Neurosci. 15:1995;6445-6452.
15. Wang M.S., et al. The WldS protein protects against axonal degeneration: a model of gene therapy for peripheral neuropathy. Ann. Neurol. 50:2001;773-779.
16. Hershko A. Mechanisms and regulation of the degradation of cyclin B. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354:1999;1571-1576.
17. Nebreda A.R., Ferby I. Regulation of the meiotic cell cycle in oocytes. Curr. Opin. Cell Biol. 12:2000;666-675.
18. 2+ oscillations promote APC/C-dependent cyclin B1 degradation during metaphase arrest and completion of meiosis in fertilizing mouse eggs. Curr. Biol. 12:2002;746-750.
19. Schlaepfer W.W., et al. Persistence of immunoreactive neurofilament protein breakdown products in transected rat sciatic nerve. J. Neurochem. 43:1984;857-864.
20. Wang M., et al. The gene for slow Wallerian degeneration (Wld(s)) is also protective against vincristine neuropathy. Neurobiol. Dis. 8:2001;155-161.
21. Garcia M.L., Cleveland D.W. Going new places using an old MAP: tau, microtubules and human neurodegenerative disease. Curr. Opin. Cell Biol. 13:2001;41-48.
22. Desai A., et al. Kin I kinesins are microtubule-destabilizing enzymes. Cell. 96:1999;69-78.
23. Ramon y Cajal, S. (1991) Cajal's Degeneration and Regeneration of the Nervous System. Translated by R. M. May, Oxford University Press.
24. O'Leary D.D., Koester S.E. Development of projection neuron types, axon pathways, and patterned connections of the mammalian cortex. Neuron. 10:1993;991-1006.
25. Campbell D.S., Holt C.E. Chemotropic responses of retinal growth cones mediated by rapid local protein synthesis and degradation. Neuron. 32:2001;1013-1026.
26. Watts R.J., et al. Axon pruning during Drosophila metamorphosis: evidence for local degeneration and requirement of the ubiquitin-proteasome system. Neuron. 38:2003;871-885.
27. Keller J.N., et al. The proteasome in brain aging. Ageing Res. Rev. 1:2002;279-293.
28. Alves-Rodrigues A., et al. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci. 21:1998;516-520.
29. McNaught K.S., et al. Failure of the ubiquitin-proteasome system in Parkinson's disease. Nat. Rev. Neurosci. 2:2001;589-594.
30. Jiang Y.H., et al. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron. 21:1998;799-811.
31. Moss A., et al. A role of the ubiquitin-proteasome system in neuropathic pain. J. Neurosci. 22:2002;1363-1372.
32. Saigoh K., et al. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat. Genet. 23:1999;47-51.
33. Ferri A., et al. Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease. Curr. Biol. 13:2003;669-673.
34. Samsam M., et al. The Wlds mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy. J. Neurosci. 23:2003;2833-2839.
35. Ehlers M.D. Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat. Neurosci. 6:2003;231-242.